Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-18 Sale | 2022-01-18 9:04 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 4,368 | $3.1918 | $13,942 | 7,336 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 9:03 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 4,368 | $3.1918 | $13,942 | 7,336 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 2,121 | $3.1918 | $6,770 | 3,529 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CEO | 11,096 | $3.1918 | $35,416 | 12,312 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 6,018 | $3.552 | $21,376 | 3,754 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 4,846 | $3.5539 | $17,222 | 1,749 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 4,624 | $3.5544 | $16,435 | 1,383 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CEO | 17,408 | $3.5545 | $61,877 | 3,356 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 9:08 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 3,490 | $4.0642 | $14,184 | 5,873 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 9:06 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,070 | $4.0642 | $4,349 | 1,755 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 9:05 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 849 | $4.0642 | $3,451 | 1,388 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 9:04 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CEO | 5,532 | $4.0642 | $22,483 | 6,172 (Direct) | View |
| 2021-09-01 Sale | 2021-09-01 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CEO | 2,782 | $5.195 | $14,452 | 3,070 (Direct) | View |
| 2021-08-02 Sale | 2021-08-02 5:09 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 2,939 | $3.5848 | $10,536 | 4,873 (Direct) | View |
| 2021-07-02 Sale | 2021-07-02 8:01 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 4,375 | $4.2649 | $18,659 | 7,329 (Direct) | View |
| 2021-07-02 Sale | 2021-07-02 8:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,907 | $4.2649 | $8,133 | 3,170 (Direct) | View |
| 2021-06-28 Sale | 2021-06-28 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CEO | 2,794 | $4.37 | $12,210 | 3,058 (Direct) | View |
| 2021-06-01 Purchase | 2021-06-03 4:31 pm | Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director | 12,600 | $0.79 | $9,954 | 143,364 (Indirect Direct) | View |
| 2021-01-19 Sale | 2021-01-19 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 2,111 | $5.6695 | $11,968 | 3,539 (Direct) | View |
| 2021-01-19 Sale | 2021-01-19 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 4,358 | $5.6695 | $24,708 | 7,346 (Direct) | View |
| 2021-01-19 Sale | 2021-01-19 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CEO | 9,879 | $5.6695 | $56,009 | 13,529 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-04 Option Award | 2022-05-04 9:03 pm | N/A 2032-05-04 | Adaptimmune Therapeutics PLC | ADAP | Brewer Joanna Elizabeth Chief Scientific Officer | 557,304 | $0 | 557,304 (Direct) | View |
| 2022-01-31 Option Award | 2022-01-31 9:05 pm | N/A 2032-01-31 | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 4,466,376 | $0 | 4,466,376 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:04 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,721,328 | $0 | 1,721,328 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:03 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 1,721,328 | $0 | 1,721,328 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:03 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin CFO | 1,721,328 | $0 | 1,721,328 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:02 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 2,581,968 | $0 | 2,581,968 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:00 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 1,721,328 | $0 | 1,721,328 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:00 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CEO | 5,737,704 | $0 | 5,737,704 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:03 pm | 2022-07-01 2031-07-01 | Adaptimmune Therapeutics PLC | ADAP | Zaks Tal Zvi Director | 379,788 | $0 | 379,788 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:03 pm | 2022-07-01 2031-07-01 | Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director | 505,918 | $0 | 505,918 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:03 pm | 2022-07-01 2031-07-01 | Adaptimmune Therapeutics PLC | ADAP | Furey John Director | 379,788 | $0 | 379,788 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:02 pm | 2022-07-01 2031-07-01 | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 379,788 | $0 | 379,788 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:01 pm | 2022-07-01 2031-07-02 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 474,385 | $0 | 474,385 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:01 pm | 2022-07-01 2031-07-01 | Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director | 579,494 | $0 | 579,494 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:01 pm | 2022-07-01 2031-07-01 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 474,385 | $0 | 474,385 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:00 pm | 2022-07-01 2031-07-01 | Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director | 379,788 | $0 | 379,788 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-03 9:01 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | 1,785,000 | $0.157 | 1,800,000 (Direct) | View |